Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R M Califf

Showing results (271-280 of 567) with videos related to

Pageof 57
Sort By:
Journal of the American College of Cardiology|May 1, 1992
Confronting the issues of patient safety and investigator conflict of interest in an international clinical trial of myocardial reperfusion. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries (GUSTO) Steering CommitteeE J Topol, P Armstrong, F Van de Werf, et al.
Circulation|September 1, 1990
Consequences of reocclusion after successful reperfusion therapy in acute myocardial infarction. TAMI Study GroupE M Ohman, R M Califf, E J Topol, et al.
Journal of the American College of Cardiology|December 1, 1988
Administration of thrombolytic therapy in the community hospital: established principles and unresolved issuesD B Mark, M A Hlatky, C M O'Connor, et al.
The American Journal of Cardiology|January 1, 1984
Prognostic indicators from radionuclide angiography in medically treated patients with coronary artery diseaseD B Pryor, F E Harrell, K L Lee, et al.
The American Journal of Cardiology|July 1, 1993
Long-term outcome following successful reopening of abrupt closure after coronary angioplastyA N Tenaglia, D F Fortin, D J Frid, et al.
European Heart Journal|February 8, 2003
Time-based risk assessment after myocardial infarction. Implications for timing of discharge and applications to medical decision-makingL K Newby, V Hasselblad, P W Armstrong, et al.
Journal of the American College of Cardiology|July 18, 2000
Occurrence and clinical significance of pseudothrombocytopenia during abciximab therapyD C Sane, L V Damaraju, E J Topol, et al.
The American Journal of Cardiology|March 12, 1999
Support for the open-artery hypothesis in survivors of acute myocardial infarction: analysis of 11,228 patients treated with thrombolytic therapyJ A Puma, M H Sketch, T D Thompson, et al.
Journal of the American College of Cardiology|March 15, 1994
Clinical importance of thrombocytopenia occurring in the hospital phase after administration of thrombolytic therapy for acute myocardial infarction. The Thrombolysis and Angioplasty in Myocardial Infarction Study GroupR A Harrington, D C Sane, R M Califf, et al.
Journal of the American College of Cardiology|July 1, 1997
Influence of diabetes mellitus on clinical outcome in the thrombolytic era of acute myocardial infarction. GUSTO-I Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary ArteriesK H Mak, D J Moliterno, C B Granger, et al.
Pageof 57

Showing results (271-280 of 567) with videos related to

Sort By:
Pageof 57
Journal of the American College of Cardiology|May 1, 1992
Confronting the issues of patient safety and investigator conflict of interest in an international clinical trial of myocardial reperfusion. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries (GUSTO) Steering CommitteeE J Topol, P Armstrong, F Van de Werf, et al.
Circulation|September 1, 1990
Consequences of reocclusion after successful reperfusion therapy in acute myocardial infarction. TAMI Study GroupE M Ohman, R M Califf, E J Topol, et al.
Journal of the American College of Cardiology|December 1, 1988
Administration of thrombolytic therapy in the community hospital: established principles and unresolved issuesD B Mark, M A Hlatky, C M O'Connor, et al.
The American Journal of Cardiology|January 1, 1984
Prognostic indicators from radionuclide angiography in medically treated patients with coronary artery diseaseD B Pryor, F E Harrell, K L Lee, et al.
The American Journal of Cardiology|July 1, 1993
Long-term outcome following successful reopening of abrupt closure after coronary angioplastyA N Tenaglia, D F Fortin, D J Frid, et al.
European Heart Journal|February 8, 2003
Time-based risk assessment after myocardial infarction. Implications for timing of discharge and applications to medical decision-makingL K Newby, V Hasselblad, P W Armstrong, et al.
Journal of the American College of Cardiology|July 18, 2000
Occurrence and clinical significance of pseudothrombocytopenia during abciximab therapyD C Sane, L V Damaraju, E J Topol, et al.
The American Journal of Cardiology|March 12, 1999
Support for the open-artery hypothesis in survivors of acute myocardial infarction: analysis of 11,228 patients treated with thrombolytic therapyJ A Puma, M H Sketch, T D Thompson, et al.
Journal of the American College of Cardiology|March 15, 1994
Clinical importance of thrombocytopenia occurring in the hospital phase after administration of thrombolytic therapy for acute myocardial infarction. The Thrombolysis and Angioplasty in Myocardial Infarction Study GroupR A Harrington, D C Sane, R M Califf, et al.
Journal of the American College of Cardiology|July 1, 1997
Influence of diabetes mellitus on clinical outcome in the thrombolytic era of acute myocardial infarction. GUSTO-I Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary ArteriesK H Mak, D J Moliterno, C B Granger, et al.
Pageof 57